Issho Genki Squalene iP6 - A Gift from Nature Discovered by Medical Science

60 Years of Research

For over 60 years Dr. Ryosuke Yokota and his son, Dr. Takashi have been researching ways of preventing diseases and premature aging. They have found that dietary Squalene is a vital bionutrient in boosting the immune system, lowering bad cholesterol level, preventing cancer and enhancing the skin.

After many years of clinical research they have reason to conclude that Squalene supplementation should be a part of your family's health strategy in preventing premature aging and other diseases. This website is dedicated to help you understand pure and natural Squalene and the best way to obtain it.


Founded in 1875 The University of Toronto's Hospital for Sick Children is an internationally renowned research institution with 3,500 doctors committed to excelling in basic and clinical research that leads to improved understanding, prevention, treatment and cure of children's diseases.
Squalene iP6 Research Under the supervision of Dr. Sylvain Baruchel, Senior Oncologist and Director of New Agent and Innovative Therapy Programs, a team of scientists are continually discovering the strong chemopotentiating and cyto-protective properties of pure and natural Squalene. Some of the areas of research is Squalene's effects on neuroblastoma cancer cells, a very common type of cancer among children. The Hospital has also been able to establish a pathological assay in order to create a standard for Squalene purity. Studies show that many natural food products claiming to be Squalene are nothing more than raw fish liver oils that contain Squalene.

www.aacr.org

Founded in 1907, the American Association for Cancer Research (AACR), is a scientific society of over 15,000 laboratory and clinical cancer researchers. It facilitates the communication and dissemination of knowledge among scientists and others dedicated to the cancer problem, as well as fosters research in cancer and related biomedical sciences, to encourage presentation

and discussion of new and important observations in the field. It also fosters public education, science education, and training; to advance the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.

The 92nd AACR Annual Conference
New Orleans, Louisiana, March 24-28, 2001

Scientists from all over world who attended the recently concluded Conference received with great interest the presentation by Dr. Sylvain Baruchel and Dr. Bikul Das of the Hospital for Sick Children. The highlights of the presentation were as follows:

1. Squalene iP6 can inhibit the growth of neuroblastoma, the third most common cancer found in children. The neuroblastoma is a dreaded cancer that continues to kill many children every year. The findings have provided hope for the effective treatment of the neuroblastoma.

2. Squalene iP6 can stimulate human bone marrow stem cell growth. Thus it may be used as an adjunct in bone marrow failure following cancer chemotherapy. Many children exposed to cancer drugs suffer from severe bone marrow failure leading to death. With Squalene iP6, the success rate of bone marrow transplantation is increased.

3. Squalene iP6 has the potential to reduce the side effects of cancer drugs, mainly Cisplatin, an important cancer drug that has many side effects.

Squalene iP6 is the exclusive formula high purity Squalene supplied by the Issho Genki Corporation.

The 2003 Research Result (in cell culture):

<<Click here to enlarge>>

In Vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity: implications in cancer chemotheraphy.

B.Das, H.Yeger, H.Baruchel, M.H.Freedman, G.Koren, S.Baruchel

Published in the European Journal of Cancer, this study proves that
Isshō Genki Squalene iP6 actively protects the cells against cancer chemotheraphy.

Download the full article?
We will give out the full article only on individual's request

The latest presentation at AACR by the Research Team of the Hospital for Sick Children Toronto Canada about the research result in animal models has further supported the 2003 research (in cell culture) to be published in the European Journal of Cancer.

Copyright © 2001, Issho Genki International. All right reserved.
Terms & Conditions | Privacy Policy